Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ACACB | O00763 | 3/20 | 0.52 |
| ▸ | ACACA | Q13085 | 2/20 | 0.52 |
| ▸ | TP53 | P04637 | 2/20 | 0.50 |
| ▸ | MITF | O75030 | 1/20 | 0.50 |
| ▸ | NCOA3 | Q9Y6Q9 | 1/20 | 0.50 |
| ▸ | PSMB5 | P28074 | 1/20 | 0.47 |
| ▸ | LMNA | P02545 | 3/20 | 0.46 |
| ▸ | ATM | Q13315 | 1/20 | 0.46 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.46 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.45 |
| ▸ | SMN1; SMN2 | Q16637 | 5/20 | 0.44 |
| ▸ | SMPD1 | P17405 | 1/20 | 0.44 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.44 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.44 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.44 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.44 |
| ▸ | HTT | P42858 | 1/20 | 0.44 |
| ▸ | AR | P10275 | 1/20 | 0.44 |
| ▸ | MAPT | P10636 | 4/20 | 0.44 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6112849 | 0.88 | ACACB (0.54) | ACACBACACATP53MITFNCOA3 | |
| SCHEMBL6113038 | 0.88 | ACACB (0.54) | ACACBACACATP53MITFNCOA3 | |
| SCHEMBL6112925 | 0.85 | ACACB (0.49) | ACACBLMNAFFAR1HTTAR | |
| SCHEMBL6117024 | 0.82 | NPC1 (0.47) | LMNASMN1; SMN2CYP1A2CYP2D6CYP2C9 | |
| SCHEMBL8795031 | 0.76 | ACACB (0.47) | ACACBTP53MITFNCOA3LMNA | |
| SCHEMBL14539768 | 0.75 | L3MBTL1 (0.52) | TP53LMNAMAPK1SMN1; SMN2HTT | |
| SCHEMBL14340625 | 0.73 | PPARG (0.55) | LMNAMAPK1SMN1; SMN2CYP1A2CYP2D6 | |
| SCHEMBL27512257 | 0.73 | AR (0.55) | LMNASMN1; SMN2CYP1A2CYP2D6CYP2C9 | |
| SCHEMBL6112818 | 0.72 | FFAR1 (0.51) | ACACBFFAR1SMN1; SMN2MAPT | |
| SCHEMBL8795215 | 0.72 | ACACB (0.51) | ACACBTP53LMNAFFAR1SMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 20 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8754112-B2 | Sulfone derivative | DAIICHI SANKYO COMPANY, LIMITED (JP) | 2014-06-17 | — | — | US | disclosed |
| US-8754112-B2 | Sulfone derivative | DAIICHI SANKYO COMPANY, LIMITED (JP) | 2014-06-17 | — | — | US | disclosed |
| US-8754112-B2 | Sulfone derivative | DAIICHI SANKYO COMPANY, LIMITED (JP) | 2014-06-17 | — | — | US | disclosed |
| EP-2463279-B1 | 4-(1,2,4-dioxazol-3-yl)benzamides for the treatment of diabetes and obesity | DAIICHI SANKYO CO LTD (JP) | 2014-02-12 | — | — | EP | disclosed |
| EP-2463279-B1 | 4-(1,2,4-dioxazol-3-yl)benzamides for the treatment of diabetes and obesity | DAIICHI SANKYO CO LTD (JP) | 2014-02-12 | — | — | EP | disclosed |
| EP-2468737-B1 | SULFONE DERIVATIVE | DAIICHI SANKYO CO LTD (JP) | 2013-10-30 | — | — | EP | disclosed |
| US-8557802-B2 | Amide derivative | DAIICHI SANKYO COMPANY, LIMITED (JP) | 2013-10-15 | — | — | US | disclosed |
| US-8557802-B2 | Amide derivative | DAIICHI SANKYO COMPANY, LIMITED (JP) | 2013-10-15 | — | — | US | disclosed |
| US-8557802-B2 | Amide derivative | DAIICHI SANKYO COMPANY, LIMITED (JP) | 2013-10-15 | — | — | US | disclosed |
| CN-102574823-A | Amide derivative | DAIICHI SANKYO CO LTD | 2012-07-11 | — | — | CN | disclosed |
| CN-102548977-A | Sulfone derivative | DAICHI SANKYO CO LTD | 2012-07-04 | — | — | CN | disclosed |
| EP-2468737-A1 | SULFONE DERIVATIVE | Daiichi Sankyo Company, Limited (JP) | 2012-06-27 | — | — | EP | disclosed |
| EP-2463279-A1 | AMIDE DERIVATIVE | Daiichi Sankyo Company, Limited (JP) | 2012-06-13 | — | — | EP | disclosed |
| US-20120129832-A1 | AMIDE DERIVATIVE | DAIICHI SANKYO COMPANY, LIMITED (JP) | 2012-05-24 | — | — | US | disclosed |
| US-20120129891-A1 | SULFONE DERIVATIVE | DAIICHI SANKYO COMPANY, LIMITED (JP) | 2012-05-24 | — | — | US | disclosed |
| US-20120129891-A1 | SULFONE DERIVATIVE | DAIICHI SANKYO COMPANY, LIMITED (JP) | 2012-05-24 | — | — | US | disclosed |
| US-20120129832-A1 | AMIDE DERIVATIVE | DAIICHI SANKYO COMPANY, LIMITED (JP) | 2012-05-24 | — | — | US | disclosed |
| US-20120129832-A1 | AMIDE DERIVATIVE | DAIICHI SANKYO COMPANY, LIMITED (JP) | 2012-05-24 | — | — | US | disclosed |
| WO-2011016470-A1 | SULFONE DERIVATIVE | 第一三共株式会社 (JP) | 2011-02-10 | — | — | WO | disclosed |
| WO-2011016469-A1 | AMIDE DERIVATIVE | 第一三共株式会社 (JP) | 2011-02-10 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120129832-A1 | AMIDE DERIVATIVE | SLC5A1, SLC5A2, SLC2A1 | ACACB 76/4885ACACA 31/4885TP53 3717/4885 |
| US-20120129891-A1 | SULFONE DERIVATIVE | SLC5A1, SLC5A2, SLC2A1 | ACACB 2250/4885ACACA 1675/4885TP53 3331/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.